The deal, which is expected to close in the second quarter, was finally done for $3.85 (£1.92) per outstanding share, for a total price of $213 million (£106.5m) – up from EMC's initial offer of $178.1 million (£89m) on March 11 which Iomega rejected. EMC boosted its offer to $205.5 million (£102.75m) on March 17, prompting Iomega to begin serious negotiations.
By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.
According to EMC's senior director of product marketing Barry Ader, not much about Iomega's products is expected to change over the next six months. Iomega has partnered with EMC since 2004, and announced it would integrate Lifeline into its upcoming StorCenter Network Hard Drive products expected this summer. Those plans will continue, Ader said, as EMC's primary interest in Iomega is its channel and brand recognition in the consumer and SMB space.
"The key things for EMC were their strong brand in the consumer and SMB market, as well as their strong relationships with distributors in that market, including Best Buy, Staples, Apple and Office Depot," Ader said.
It is too early to talk about other future product changes or integration, Ader said. But he gave Retrospect customers encouraging news by saying the backup product, which has languished over the last year, especially on the Mac side, will receive more development attention within this new division. "We will continue to invest in Retrospect and bring it to market through the very nice channels Iomega already has," Ader said.
Iomega was able to hold out during these negotiations as EMC's only real acquisition option in the consumer storage space. Imation also makes removable disk storage, but it doesn't have the kind of diversified business that Iomega has. Western Digital has had some consumer success with its MyBook external hard drives, but it doesn't offer its own backup software.
If EMC hadn't been able to close this deal or find a suitable replacement for Iomega, analysts predicted it would have had to partner to get a foot in the door in the consumer space or bite the bullet and repackage its existing brand – both much more difficult and costly propositions.